Biovaxys Technology Corp (TSE:BIOV) has released an update.
BioVaxys Technology Corp. has announced it will continue to provide bi-weekly updates regarding its management cease trade order, which remains in effect following the company’s inability to file its annual financial statements by the prescribed deadline. The firm anticipates the necessary financial documents will be filed by March 30, 2024, and asserts that there are no significant corporate changes or insolvency proceedings affecting the company currently.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.
